You are here

AstraZeneca

FDA grants accelerated approval to Enhertu for metastatic HER2-positive cancers

Investing.com

Sun, 04/7/24 - 04:45 pm

AstraZeneca’s Imfinzi tackles another type of lung cancer with latest trial win

Fierce Pharma

Fri, 04/5/24 - 11:28 am

clinical trials

limited-stage small cell lung cancer

Fierce Biotech's Quarterly IPO and M&A Roundup: Q1'24

Fierce Biotech

Wed, 04/3/24 - 11:36 am

Kyverna Therapeutics

Contineum Therapeutics

CymaBay Therapeutics

Gilead Sciences

Fusion Pharmaceuticals

AZ, Daiichi Sankyo file Dato-DXd for second indication

Pharmaphorum

Tue, 04/2/24 - 11:31 am

AstraZeneca CEO's 2024 pay proposal under fire from influential proxy advisers

Fierce Pharma

Mon, 04/1/24 - 11:18 pm

executive compensation

AstraZeneca Gets FDA Approval in Boost to Rare Disease Franchise

BioSpace

Mon, 04/1/24 - 11:58 am

AstraZeneca CEO ‘deeply humbled’ by award recognizing pandemic efforts

Biopharma Reporter

Thu, 03/28/24 - 11:18 am

Brainomix AI shows its worth in AZ pulmonary fibrosis trial

Pharmaphorum

Wed, 03/27/24 - 10:55 am

artificial intelligence

Big Pharma CEOs gather in Beijing to ⁠show continued interest in China, offer policy advice

Fierce Pharma

Tue, 03/26/24 - 04:26 pm

Bristol Myers Squibb

AstraZeneca’s rare disease unit overcomes FDA snub to expand Ultomiris in NMOSD

Fierce Pharma

Mon, 03/25/24 - 10:31 pm

GSK joins AstraZeneca, Boehringer in capping US out-of-pocket inhaler prices at $35 per month

Fierce Pharma

Thu, 03/21/24 - 06:37 pm

Boehringer Ingelheim

Merck combination treatment for lung cancer fails late-stage study

Reuters

Thu, 03/21/24 - 11:13 am

non small cell lung cancer

BMS racks up phase III win in liver cancer targeted by AstraZeneca and Roche

BioSpace

Wed, 03/20/24 - 11:51 am

Bristol Myers Squibb

immuno-oncology

AstraZeneca scoops up Fusion Pharmaceuticals in $2.4B radiopharma deal

Medical Marketing and Media

Tue, 03/19/24 - 11:58 am

Fusion Pharmaceuticals

radiopharmaceuticals

AstraZeneca Shows Lynparza Combo Could Address Unmet Endometrial Cancer Need

BioSpace

Mon, 03/18/24 - 05:19 pm

endometrial cancer

BMS, AstraZeneca, Novartis Add to 2024 M&A Upswing

BioSpace

Mon, 03/18/24 - 11:10 am

Bristol Myers Squibb

AstraZeneca follows rival Boehringer in capping out-of-pocket costs for inhalers

Reuters

Mon, 03/18/24 - 11:05 am

Boehringer Ingelheim

Bevespi Aerosphere

Breztri Aerosphere

AstraZeneca boosts rare disease portfolio with $1.05B Amolyt acquisition

BioSpace

Thu, 03/14/24 - 11:38 am

hypoparathyroidism

AstraZeneca kick-starts Phase III COPD trial for Breztri

Clinical Trials Arena

Thu, 03/14/24 - 11:21 am

clinical trials

RSV monoclonal Beyfortus was 90% effective at preventing hospitalizations in children this winter

Stat

Thu, 03/7/24 - 05:35 pm

monoclonal antibodies

Pages